Seer (SEER) Stock Price, News & Analysis

Company Overview

Seer, Inc., a life sciences company, engages in developing and commercializing products to decode the biology of the proteome. It develops Proteograph Product Suite, an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation, and software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only. The company intends to sell its products for research use only, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. It operates in China, Australia, Eastern Europe, Israel, and Japan. The company was formerly known as Seer Biosciences, Inc. and changed its name to Seer, Inc. in July 2018. Seer, Inc. was incorporated in 2017 and is headquartered in Redwood City, California.

Key Stats

• Today's Range: $1.95 to $2.03
• 50-Day Range: $1.85 to $2.28
• 52-Week Range: $1.56 to $2.63
• Volume: 160,059 shs
• Average Volume: 328,830 shs
• Market Capitalization: $116.56 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $3.00
• Consensus Rating: Hold

Seer Stock Analysis - MarketRank™

Seer scored higher than 55% of companies evaluated by MarketBeat, and ranked 506th out of 932 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.0 / 5
• Analyst Rating: Hold

Consensus Rating

Seer has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 1 hold rating, and no sell ratings.

Amount of Analyst Coverage

Seer has received no research coverage in the past 90 days.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: Decreasing

Earnings Growth

Earnings for Seer are expected to decrease in the coming year, from ($1.42) to ($1.66) per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Seer is -1.40, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Seer is -1.40, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

Seer has a P/B Ratio of 0.36. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

5.58% of the float of Seer has been sold short.

Short Interest Ratio / Days to Cover

Seer has a short interest ratio ("days to cover") of 6.

Change versus previous month

Short interest in Seer has recently decreased by 10.05%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Seer does not currently pay a dividend.

Dividend Growth

Seer does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

5.58% of the float of Seer has been sold short.

Short Interest Ratio / Days to Cover

Seer has a short interest ratio ("days to cover") of 6.

Change versus previous month

Short interest in Seer has recently decreased by 10.05%, indicating that investor sentiment is improving significantly.

News and Social Media

• Score: 2.3 / 5
• News Sentiment: 0.11

News Sentiment

Seer has a news sentiment score of 0.11. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.57 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 7 news articles for Seer this week, compared to 5 articles on an average week.

Search Interest

3 people have searched for SEER on MarketBeat in the last 30 days. This is an increase of 200% compared to the previous 30 days.

Company Ownership

• Score: 3.3 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, Seer insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $62,926.00 in company stock.

Percentage Held by Insiders

11.28% of the stock of Seer is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

75.20% of the stock of Seer is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

SEER Stock Analysis - Frequently Asked Questions

How have SEER shares performed this year?

Seer's stock was trading at $2.31 at the beginning of 2025. Since then, SEER shares have decreased by 14.3% and is now trading at $1.98.
View the best growth stocks for 2025 here.

How were Seer's earnings last quarter?

Seer, Inc. (NASDAQ:SEER) posted its earnings results on Tuesday, May, 13th. The company reported ($0.34) earnings per share for the quarter, beating analysts' consensus estimates of ($0.37) by $0.03. The firm earned $4.21 million during the quarter, compared to analyst estimates of $3.25 million. Seer had a negative net margin of 560.90% and a negative trailing twelve-month return on equity of 24.69%.
Read the conference call transcript.

When did Seer IPO?

Seer (SEER) raised $150 million in an initial public offering on Friday, December 4th 2020. The company issued 8,800,000 shares at $16.00-$18.00 per share. J.P. Morgan, Morgan Stanley, BofA Securities and Cowen served as the underwriters for the IPO.

Who are Seer's major shareholders?

Seer's top institutional shareholders include Jacobs Levy Equity Management Inc. (0.61%), Jane Street Group LLC (0.43%), Invesco Ltd. (0.32%) and Goldman Sachs Group Inc. (0.29%). Insiders that own company stock include Omid Farokhzad, David R Horn, Elona Kogan, Elona Esq Kogan, Scott D Thomas and Dipchand Nishar.
View institutional ownership trends.

How do I buy shares of Seer?

Shares of SEER stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Seer own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Seer investors own include fuboTV (FUBO), NIO (NIO), Advanced Micro Devices (AMD), Peloton Interactive (PTON), Tesla (TSLA) and Lemonade (LMND).

Company Calendar

• Last Earnings: 5/13/2025
• Today: 6/18/2025
• Next Earnings (Estimated): 8/06/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: MED - BIOMED/GENE
• Sub-Industry: Measuring And Control Equipment
• Current Symbol: NASDAQ:SEER
• CIK: 1726445
• Web: www.seer.bio
• Phone: 650-453-0000
• Fax: N/A
• Employees: 160
• Year Founded: N/A

Price Target and Rating

• Average Stock Price Target: $3.00
• High Stock Price Target: $3.00
• Low Stock Price Target: $3.00
• Potential Upside/Downside: +51.5%
• Consensus Rating: Hold
• Rating Score (0-4): 2.00
• Research Coverage: 1 Analysts

Profitability

• EPS (Most Recent Fiscal Year): ($1.41)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$86.60 million
• Net Margins: -560.90%
• Pretax Margin: -559.60%
• Return on Equity: -24.69%
• Return on Assets: -22.13%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 19.34
• Quick Ratio: 18.81

Sales & Book Value

• Annual Sales: $14.17 million
• Price / Sales: 8.23
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $5.54 per share
• Price / Book: 0.36

Miscellaneous

• Outstanding Shares: 58,870,000
• Free Float: 52,229,000
• Market Cap: $116.56 million
• Optionable: Optionable
• Beta: 1.54